Symbols / IMAB
IMAB Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-26 09:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- What Makes IMab (IMAB) a New Buy Stock - Yahoo Finance Mon, 06 Oct 2025 07
- I-Mab Biopharma Stock: Caution Warranted After Huge Surge (NASDAQ:IMAB) - Seeking Alpha ue, 14 Oct 2025 07
- I-Mab stock price target raised to $10 by Jefferies on rebranding, new asset - Investing.com Fri, 17 Oct 2025 07
- I-Mab Sponsored ADR (IMAB) is a Great Momentum Stock: Should You Buy? - Nasdaq Fri, 06 Jun 2025 07
- $37M Visara Launch: I-Mab Rebrands as NovaBridge, Pursues Hong Kong IPO and Acquires VIS-101 - Stock Titan hu, 16 Oct 2025 07
- NovaBridge Biosciences Unveils New Identity and Strategic Direction - The Globe and Mail hu, 30 Oct 2025 07
- I-Mab (IMAB) Shares Drop Amid Rebranding and Strategic Shift - GuruFocus Fri, 17 Oct 2025 07
- I-Mab's (NASDAQ:IMAB) market cap surged US$52m last week, individual investors who have a lot riding on the company were rewarded - Yahoo Finance Sat, 11 Oct 2025 07
- Spotlight On 3 Promising Penny Stocks With Over $20M Market Cap - simplywall.st Mon, 04 Aug 2025 07
- I-Mab stock down after new business model (IMAB:NASDAQ) - Seeking Alpha Fri, 17 Oct 2025 07
- I-Mab Sponsored ADR (IMAB) Is Up 24.14% in One Week: What You Should Know - Nasdaq Fri, 10 Oct 2025 07
- IMAB Stock Price, News & Analysis - Stock Titan Fri, 25 Apr 2025 00
- I-Mab (IMAB) Unveils Strategic Shift with New Business Model and Dual Listing Plan - GuruFocus hu, 16 Oct 2025 07
- I-Mab (IMAB) Shows 83% Response Rate for Givastomig in Metastatic Gastric Cancer - Yahoo Finance ue, 23 Sep 2025 07
- I-Mab: Sudden Pivot To Gastric Cancer Med Still Underappreciated By Market (NASDAQ:IMAB) - Seeking Alpha Wed, 10 Sep 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for IMAB
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|